Human papillomavirus vaccine - GlaxoSmithKlineAlternative Names: HPV-16 E7/AS02B vaccine - GlaxoSmithKline; Human papillomavirus type 16 E7 protein-based vaccine - GlaxoSmithKline; PD-E7/AS02B vaccine
Latest Information Update: 21 Jan 2008
At a glance
- Originator GlaxoSmithKline
- Class Cancer vaccines; Papillomavirus vaccines
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Human papillomavirus infections